What's breaking now, across thousands of outlets.
It’s been a little more than a year since Omada Health went public, and the company reported its first profitable quarter this spring. Now, it's preparing for its first CEO transition. Wei-Li Shao, who joined ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Experts warn that the new drug might be beckoning a new wave of the country’s opioid crisis.
Living in a disadvantaged neighbourhood may be linked to poorer brain health, with researchers finding higher brain age, lower total brain volume and more signs of vascular damage in people living in…
In a study analyzing nearly 3,000 brain MRI exams, researchers found that living in highly disadvantaged neighborhoods was associated with adverse brain health.
Kiffen ist inzwischen mit vielen Auflagen für Erwachsene erlaubt. Zugleich wächst der Markt für Cannabis als Medikament stark. Der neue Minister will dem einen Riegel vorschieben.
The French biotech Axoltis Pharma reported a Phase 2 failure in ALS on Tuesday morning, but suggested it found a small signal to move the drug forward amid a noisy dataset.
Thousands of people visit emergency departments with headaches every year, but research suggests the way these visits are recorded may be hiding important clues about patients' needs.
